Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitors

Jiao, TY; Tang, HW; Zhang, WW; Hu, BY; Wan, T; Cao, YB; Zhang, Z; Wang, YF; Cao, JN; Cui, MQ; Lu, SC

Lu, SC (通讯作者)，Chinese Peoples Liberat Army Gen Hosp, Fac Hepatopancreato Biliary Surg, Med Ctr 1, Beijing 100853, Peoples R China.;Lu, SC (通讯作者)，Inst Hepatobiliary Surg Chinese PLA, Beijing, Peoples R China.;Lu, SC (通讯作者)，PLA, Key Lab Digital Hepetobiliary Surg, Beijing, Peoples R China.;Lu, SC (通讯作者)，Nankai Univ, Sch Med, Tianjin, Peoples R China.;Lu, SC (通讯作者)，Chinese PLA Gen, Fac Hepatopancreatobiliary Surg, Beijing, Peoples R China.

BMC SURGERY, 2023; 23 (1):

Abstract

BackgroundIt is controversial whether patients with hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) should undergo salvage surge......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索